PPA
ABEO icon

Parametric Portfolio Associates’s Abeona Therapeutics ABEO Stock Holding History

Parametric Portfolio Associates’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-435
Closed -$11K – 3987
2020
Q3 		$11K Sell
435
-104
-19% -$6.56K ﹤0.01% 3914
2020
Q2 		$39K Sell
539
-686
-56% -$47.4K ﹤0.01% 3879
2020
Q1 		$64K Sell
1,225
-1,374
-53% -$91.8K ﹤0.01% 3799
2019
Q4 		$213K Buy
2,599
+946
+57% +$66.8K ﹤0.01% 3718
2019
Q3 		$93K Buy
1,653
+1,032
+166% +$77.3K ﹤0.01% 3844
2019
Q2 		$74K Buy
+621
New +$104K ﹤0.01% 3876
2018
Q1 		– Sell
-2,325
Closed -$921K – 3931
2017
Q4 		$921K Buy
+2,325
New +$962K ﹤0.01% 3060

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parametric Portfolio Associates's ABEO Position: Q4 2020 in Review

Parametric Portfolio Associates sold out of Abeona Therapeutics (ABEO) in Q4 2020, closing a stake of 435 shares — an estimated $11K sold.

Parametric Portfolio Associates first reported a position in ABEO in Q4 2017 and held it in 7 quarters. The position peaked at $921K in Q4 2017. 73 funds tracked by Wall St. Rank hold ABEO as of Q4 2020.

  • Parametric Portfolio Associates reported no remaining Abeona Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 435 Abeona Therapeutics shares in Q4 2020, an estimated $11K.
  • Parametric Portfolio Associates first reported a position in Abeona Therapeutics in Q4 2017 and held it in 7 quarters.
  • Parametric Portfolio Associates's Abeona Therapeutics position peaked at $921K in Q4 2017.
  • 73 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2020.

Based on Parametric Portfolio Associates's 13F filing for Q4 2020, filed 12 Feb 2021.